BlackRock Inc. - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$20,773,501
-25.6%
5,986,600
-0.3%
0.00%0.0%
Q2 2023$27,925,839
+20.4%
6,005,557
+19.6%
0.00%0.0%
Q1 2023$23,196,202
-40.9%
5,020,823
+3.3%
0.00%0.0%
Q4 2022$39,269,932
+76.5%
4,860,140
+21.2%
0.00%0.0%
Q3 2022$22,248,000
+14.7%
4,008,370
+7.7%
0.00%0.0%
Q2 2022$19,395,000
-36.7%
3,722,625
-0.2%
0.00%0.0%
Q1 2022$30,650,000
-44.3%
3,728,829
+0.8%
0.00%0.0%
Q4 2021$55,057,000
-20.3%
3,700,043
+1.2%
0.00%
-50.0%
Q3 2021$69,071,000
+2.4%
3,656,477
+0.8%
0.00%0.0%
Q2 2021$67,423,000
-4.5%
3,626,799
+16.9%
0.00%0.0%
Q1 2021$70,601,000
+19.7%
3,101,973
+14.1%
0.00%0.0%
Q4 2020$59,006,000
+186.7%
2,717,929
+32.7%
0.00%
+100.0%
Q3 2020$20,579,000
+176.1%
2,047,563
+113.2%
0.00%
Q2 2020$7,453,000
+10.6%
960,241
+45.3%
0.00%
Q1 2020$6,738,000
-5.3%
660,751
+2.1%
0.00%
Q4 2019$7,118,000
+21.6%
647,107
+0.5%
0.00%
Q3 2019$5,854,000
-5.5%
644,019
+18.4%
0.00%
Q2 2019$6,193,000
+72.3%
544,148
+72.4%
0.00%
Q1 2019$3,595,000
-2.7%
315,668
-23.0%
0.00%
Q4 2018$3,696,000
-27.5%
409,713
+20.5%
0.00%
Q3 2018$5,098,000339,9000.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders